Literature DB >> 15566419

Topiramate inhibits trigeminovascular neurons in the cat.

R J Storer1, P J Goadsby.   

Abstract

To facilitate understanding the action of antimigraine preventives the effect of topiramate on trigeminocervical activation in the cat was examined. Animals (n = 7) were anaesthetized and physiologically monitored. The superior sagittal sinus (SSS) was stimulated to produce a model of trigeminovascular nociceptive activation. Cumulative dose-response curves were constructed for the effect of topiramate at doses of 3, 5, 10, 30 and 50 mg/kg on SSS-evoked firing of trigeminocervical neurons. Topiramate reduced SSS evoked firing in a dose-dependent fashion. The maximum effect was seen over 30 min for the cohort taken together. At 3 mg/kg firing was reduced by 36 +/- 13% (mean +/- SEM) after 15 min. At 5 and 50 mg/kg firing was reduced by 59 +/- 6% and 65 +/- 14%, respectively, after 30 min. Inhibition of the trigeminocervical complex directly, or neurons that modulate sensory input, are plausible mechanisms for the action of preventives in migraine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566419     DOI: 10.1111/j.1468-2982.2004.00767.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  20 in total

1.  Paroxysmal hemicrania responding to topiramate.

Authors:  A S Cohen; P J Goadsby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

2.  Paroxysmal hemicrania responding to topiramate.

Authors:  A S Cohen; P J Goadsby
Journal:  BMJ Case Rep       Date:  2009-07-07

3.  Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.

Authors:  A Laine Green; Pengfei Gu; Milena De Felice; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2013-12-11       Impact factor: 6.292

Review 4.  Primary headache disorders and neuro-ophthalmologic manifestations.

Authors:  Daniel P Schwartz; Matthew S Robbins
Journal:  Eye Brain       Date:  2012-09-13

5.  Pharmacology.

Authors:  Hayrunnisa Bolay; Paul Durham
Journal:  Handb Clin Neurol       Date:  2010

Review 6.  Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Authors:  Sheryl R Haut; Marcelo E Bigal; Richard B Lipton
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

Review 7.  Chronic migraine - new treatment options.

Authors:  Adina Roceanu; Florina Antochi; Ovidiu Bajenaru
Journal:  Maedica (Buchar)       Date:  2014-12

Review 8.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 9.  Evidence-based treatments for cluster headache.

Authors:  Rubesh Gooriah; Alina Buture; Fayyaz Ahmed
Journal:  Ther Clin Risk Manag       Date:  2015-11-09       Impact factor: 2.423

10.  Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis.

Authors:  Simon Akerman; Marcela Romero-Reyes
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.